selective serotonin reuptake inhibitor

(redirected from Selective serotonin reuptake inhibitors)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to Selective serotonin reuptake inhibitors: fluoxetine, citalopram, Tricyclic antidepressants, Monoamine oxidase inhibitors

selective serotonin reuptake inhibitor

n.
An SSRI.
References in periodicals archive ?
NEW YORK -- Selective serotonin reuptake inhibitors appear to be highly effective for a range of pediatric anxiety disorders, Dr.
Whether selective serotonin reuptake inhibitors, MAO inhibitors, or tricyclics, antidepressants have proved to be the safest, most effective drugs for these patients, Dr.
Patients with depression who took venlafaxine (Effexor) had significantly greater reductions in symptoms than did those us ing other selective serotonin reuptake inhibitors or a placebo, said Dr.
Selective serotonin reuptake inhibitors (SSRIs) are the treatments of choice for treating depression in elderly patients, according to a just issued guideline.
Rushton, more than 500,000 prescriptions for selective serotonin reuptake inhibitors (SSRIs) are written for children and adolescents each year in the United States.
NEW ORLEANS -- Venlafaxine is associated with significantly higher rates of remission than selective serotonin reuptake inhibitors in major depressive disorder, Richard Entsuah, Ph.
It also offers a pioneering alternative for patients currently utilizing selective serotonin reuptake inhibitors (SSRIs).
Although selective serotonin reuptake inhibitors are effective in most cases of obsessive-compulsive disorder (OCD), 30%-40% of patients who take them show little improvement.
Earlier studies have suggested that a class of medications known as selective serotonin reuptake inhibitors, or SSRIs, can be effective in treating disorders with similar aspects, such as compulsive skin picking or compulsive shopping.
MN-305, a 5-HT1A receptor agonist, is a potentially rapid-acting agent specific for anxiety disorders that appears to be lacking the sedation of benzodiazepines (BDZs) or side effects of selective serotonin reuptake inhibitors (SSRIs) and norepinephrine reuptake inhibitors (SNRIs).
Study results are based on the evaluation of 36 patients taking selective serotonin reuptake inhibitors (SSRI), which are typically used as the first-line drug treatment for depression.
Selective serotonin reuptake inhibitors (SSRIs) are likely associated with a moderate increased risk of upper gastrointestinal (UGI) bleeding.

Full browser ?